「nor」の検索結果
19件：1～5件目を表示
-
发表论文 | 研究与开发 | 千寿制药株式会社
Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Department of Ophthalmology,...
https://www.senju.co.jp/chinese/rd/thesis/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
le-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日...
http://www.senju.co.jp/english/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
le-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日...
https://www.senju.co.jp/english/rd/society/ -
Product Development Policy | Research & Development | SENJU Pharmaceutica
llment. Corneal diseases Dry eye (DE) is a typical corneal disease. Dry eye causes discomfort and abnormal visual function owing to an unstable tear film, which may damage the ocular surface. Major sy...
http://www.senju.co.jp/english/rd/policy/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
le-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日...
https://www.senju.co.jp/rd/society/